Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The neuropsychiatry of Parkinson's disease: advances and challenges
Daniel Weintraub, Dag Aarsland, К. Ray Chaudhuri, et al.
The Lancet Neurology (2021) Vol. 21, Iss. 1, pp. 89-102
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Genetics and Pathogenesis of Parkinson's Syndrome
Hui Ye, Laurie Robak, Meigen Yu, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 95-121
Open Access | Times Cited: 209
The heterogeneity of Parkinson’s disease
Ullrich Wüllner, Per Borghammer, Chi‐un Choe, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 827-838
Open Access | Times Cited: 65
Biological factors influencing depression in later life: role of aging processes and treatment implications
Sarah M. Szymkowicz, Andrew Gerlach, Damek Homiack, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine
Shuai Jin, Lijuan Zhang, Lin Wang
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115215-115215
Open Access | Times Cited: 52
The impact of psychiatric comorbidity on Parkinson's disease outcomes: a systematic review and meta-analysis
Ella Burchill, Cameron Watson, Jack B. Fanshawe, et al.
The Lancet Regional Health - Europe (2024) Vol. 39, pp. 100870-100870
Open Access | Times Cited: 19
Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature
Ana Isabel Beltrán-Velasco, Manuel Reiriz, Sara Uceda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 3010-3010
Open Access | Times Cited: 17
Effectiveness of Acupuncture for Anxiety Among Patients With Parkinson Disease
Jingqi Fan, Wei-Jing Lu, Weiqiang Tan, et al.
JAMA Network Open (2022) Vol. 5, Iss. 9, pp. e2232133-e2232133
Open Access | Times Cited: 63
Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases
Linyan Duan, Xingfan Li, Rong Ji, et al.
Polymers (2023) Vol. 15, Iss. 9, pp. 2196-2196
Open Access | Times Cited: 39
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
Jason Aldred, Eric Freire‐Alvarez, А. В. Амелин, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1937-1958
Open Access | Times Cited: 36
Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis
Matthieu Béreau, Vincent Van Waes, Mathieu Servant, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1599-1599
Open Access | Times Cited: 23
A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn (“line 61”) Mice
Franziska Richter, Miloš Stanojlović, Christopher Käufer, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 1, pp. 97-116
Open Access | Times Cited: 22
Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice
Juntao Cui, Di Zhao, Manman Xu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Salivary Biomarkers for Parkinson’s Disease: A Systematic Review with Meta-Analysis
Kacper Nijakowski, Wojciech Owecki, Jakub Jankowski, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 340-340
Open Access | Times Cited: 8
TGF-β1 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson’s disease models and patients
Yi Zhuo, Wenshui Li, Wen Lü, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Polypharmacy and anticholinergic burden as risk factors for postoperative delirium in surgical medicine
Henriette Möllmann, Soufian Boulghoudan, Julian Kuhlmann, et al.
Zeitschrift für Gerontologie und Geriatrie (2025)
Open Access | Times Cited: 1
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
Akihisa Mori, Jiang‐Fan Chen, Shinichi Uchida, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2366-2366
Open Access | Times Cited: 36
Central and Peripheral Inflammation: Connecting the Immune Responses of Parkinson’s Disease
Gregory P. Williams, Aubrey M. Schonhoff, Alessandro Sette, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S129-S136
Open Access | Times Cited: 32
Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease: current evidence and future perspectives
Elisa Mantovani, Chiara Zucchella, Andreas A. Argyriou, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 1, pp. 25-43
Closed Access | Times Cited: 19
Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson’s Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment
Abubakar Atiq, Hyeon Jin Lee, Amjad Khan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9942-9942
Open Access | Times Cited: 19
Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedonia
Harry Costello, Yumeya Yamamori, Suzanne Reeves, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 10, pp. 863-870
Open Access | Times Cited: 17
Depression in dementia with Lewy bodies: a critical update
K. A. Jellinger
Journal of Neural Transmission (2023) Vol. 130, Iss. 10, pp. 1207-1218
Closed Access | Times Cited: 17
Research progress in the molecular mechanism of ferroptosis in Parkinson's disease and regulation by natural plant products
Kailin Yang, Liuting Zeng, Jinsong Zeng, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102063-102063
Closed Access | Times Cited: 17
Amygdala neuronal dyshomeostasis via 5‐HT receptors mediates mood and cognitive defects in Alzheimer's disease
Xinrong Wu, Xiaona Zhu, Yuan‐Bo Pan, et al.
Aging Cell (2024) Vol. 23, Iss. 8
Open Access | Times Cited: 7
The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease
Christopher B. Morrow, Jared T. Hinkle, Joseph Seemiller, et al.
American Journal of Geriatric Psychiatry (2024) Vol. 32, Iss. 6, pp. 710-720
Closed Access | Times Cited: 6
Effects of Transcranial Direct Current Stimulation on Potential P300-Related Events and Alpha and Beta EEG Band Rhythms in Parkinson's Disease
Rosa Angela Fabio, Rossella Suriano, Antonio Gangemi
Journal of Integrative Neuroscience (2024) Vol. 23, Iss. 2, pp. 25-25
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top